Skip to main content
logo
Anya Biopharm Inc. (TPEX:7776)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
32.35
+1.45 (4.69%)
At close: Sep 2, 2026

Anya Biopharm Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
13.0616.2721.62.322.5
Revenue Growth
-19.73%-24.66%831.26%-7.09%-
Gross Profit
12.9216.1321.462.232.41
Operating Income
-91.28-58.33-42.85-28.62-38.8
Net Income
-49.13-64.02-36.96-28.08-41.83
Earnings Per Share
-1.00-1.30-1.12-12.32-18.35
EPS Growth
-----

Revenue by Geography
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Europe
0.870.850.830.990.78
Taiwan
0.570.570.571.331.72
Asia
-14.8520.19--
Total
13.0616.2721.62.322.5

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
317.3370.22454.1511.462.07
Total Debt
3.522.963.41103.0365
Net Cash (Debt)
313.78367.26450.73-91.58-62.93
Net Cash Growth
-14.56%-18.52%---
Net Cash Per Share
6.397.4813.62-40.16-27.60

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-75.57-69.93-23.81-24.13-43.6
Capital Expenditures
-0.84-0.87-6.36-0.07-0.56
Free Cash Flow
-76.4-70.81-30.17-24.2-44.16
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
98.91%99.14%99.36%96.16%96.55%
Operating Margin
-698.86%-358.51%-198.43%-1233.98%-1554.37%
Pretax Margin
-361.38%-389.18%-160.75%-1209.49%-1673.92%
Profit Margin
-376.16%-393.47%-171.14%-1210.82%-1675.92%
FCF Margin
-584.97%-435.16%-139.69%-1043.60%-1769.15%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
122.18144.2585.60--